Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00002807 · ClinicalTrials.gov registry record · NA

Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery

A NA study, sponsored by NCIC Clinical Trials Group.

Completed
Registry status
NA
Development phase
116
Enrollment target

NCT00002807: Completed NA study, sponsored by NCIC Clinical Trials Group.

NCT00002807 is a NA study that has completed, run by NCIC Clinical Trials Group. The registered enrollment target is 116 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00002807, a NA study, has completed, sponsored by NCIC Clinical Trials Group.

COMPLETED
Registry status
NA
Development phase
116 participants
Enrollment target

Study Summary

RATIONALE: Radiation therapy uses high-energy x-rays to damage cancer cells. It is not yet known whether radiation therapy is more effective than observation only after sugery in treating endometrial cancer. PURPOSE: This randomized phase III trial is studying radiation therapy to see how well it works compared to observation only in treating patients with stage I or stage II endometrial cancer who have undergone hysterectomy and oophorectomy.

Interventions

  • RADIATION radiation therapy

Trial Details

FieldValue
Enrollment Target 116 participants
Start Date 1996-07-04
Est. Completion 2009-12-21
Phase NA
NCIC Clinical Trials Group

21 total trials

What the finished NCT00002807 record still lists

NCT00002807 is an interventional study that assigns participants to a tested intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 1 intervention - of which radiation therapy is the first listed.

NCT00002807 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00002807 about?

NCT00002807 is a clinical study titled "Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery". RATIONALE: Radiation therapy uses high-energy x-rays to damage cancer cells. It is not yet known whether radiation therapy is more effective than observation only after sugery in treating endometrial cancer. PURPOSE: This randomized phase III trial is studying radiation therapy to see how well it w...

What is the current status of trial NCT00002807?

This trial is currently completed. It is a NA study. The enrollment target is 116 participants. The study started on 1996-07-04. Estimated completion is 2009-12-21.

What interventions are being tested in trial NCT00002807?

The interventions under investigation include: radiation therapy (RADIATION).

Who is sponsoring clinical trial NCT00002807?

This trial is sponsored by NCIC Clinical Trials Group, which has 21 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00002807's enrollment target sits among peer trials

116 808th of 2000 higher than 1,191 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03014687 · 116 participants · Phase 4

    Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions

  • NCT03214562 · 116 participants · Phase 1

    Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia

  • NCT03847467 · 116 participants · Phase 1

    Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy

  • NCT04222413 · 116 participants · Phase 1

    Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00002807, the US trial registry maintained by the National Library of Medicine. NCT00002807 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.